High-dose (HDS) chemotherapy in multiple myeloma: Residual tumor cells are detectable in PBPC and BM cell harvests and after single or double autografting.

被引：0
|
作者：
Corradini, P [1 ]
Astolfi, M [1 ]
Ladetto, M [1 ]
Campana, S [1 ]
Comoglio, F [1 ]
Tarella, C [1 ]
Boccadoro, M [1 ]
Pileri, A [1 ]
机构：
[1] UNIV TURIN,AZ OSPED S GIOVANNI BATTISTA,DIP MED & ONCOL SPERIMENTALE,DIV EMATOL,TURIN,ITALY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：810 / 810
页数：1
相关论文
共 50 条
  • [31] Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation
    Kiel, K
    Cremer, FW
    Rottenburger, C
    Kallmeyer, C
    Ehrbrecht, E
    Atzberger, A
    Hegenbart, U
    Goldschmidt, H
    Moos, M
    BONE MARROW TRANSPLANTATION, 1999, 23 (10) : 1019 - 1027
  • [32] TRANSPLANTATION OF CD34(+) PERIPHERAL-BLOOD PROGENITOR CELLS AFTER HIGH-DOSE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA
    SCHILLER, G
    VESCIO, R
    FREYTES, C
    SPITZER, G
    SAHEBI, F
    LEE, M
    WU, CH
    CAO, J
    LEE, JC
    HONG, CH
    LICHTENSTEIN, A
    LILL, M
    HALL, J
    BERENSON, R
    BERENSON, J
    BLOOD, 1995, 86 (01) : 390 - 397
  • [33] Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation
    Vogel, W
    Kopp, HG
    Kanz, L
    Einsele, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (04) : 214 - 218
  • [34] Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation
    Wichard Vogel
    Hans-Georg Kopp
    Lothar Kanz
    Hermann Einsele
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 214 - 218
  • [35] Single agent thalidomide for treatment of first relapse following high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma.
    Hoyer, B
    Fenk, R
    Steidl, U
    Kondakci, M
    Germing, U
    Haas, R
    Kobbe, G
    BLOOD, 2003, 102 (11) : 691A - 692A
  • [36] Reapplication of High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation as Salvage Treatment for Patients with Relapsed or Refractory Multiple Myeloma - a Single Center Experience
    Fenk, Roland
    Liese, Vanessa
    Bruns, Ingmar
    Kondakci, Mustafa
    Balleisen, Sebastian
    Saure, Christian
    Schroeder, Thomas
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2009, 114 (22) : 1327 - 1328
  • [37] Single institution experience with two high-dose chemotherapy (HDC) conditioning regimens prior to autologous stem cell transplant (ASCT) for multiple myeloma (MM)
    Benson, DM
    Elder, PJ
    Lin, T
    Blum, W
    Penza, S
    Avalos, B
    Byrd, JC
    Copelan, E
    Farag, SS
    BLOOD, 2004, 104 (11) : 388B - 389B
  • [38] Pelvic and spinal MR follow-up of multiple myeloma patients after high-dose chemotherapy and autologous peripheral blood stem cell transplant
    Dumas, A.
    Chiavassa-Gandois, H.
    Sans, N.
    Delaunay, F.
    Lemaire, O.
    Laroche, M.
    Railhac, J. J.
    JOURNAL DE RADIOLOGIE, 2009, 90 (11): : 1703 - 1714
  • [39] Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors
    G Reich
    MY Mapara
    P Reichardt
    B Dörken
    G Maschmeyer
    Bone Marrow Transplantation, 2001, 27 : 525 - 529
  • [40] Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma - a phase 1 study
    S Trudel
    Z Li
    C Dodgson
    S Nanji
    Y Wan
    M Voralia
    M Hitt
    J Gauldie
    FL Graham
    AK Stewart
    Leukemia, 2001, 15 : 846 - 854
12345